If you need more lookups,
subscriptions start at $34 USD/month.
Tim Schenk Location
Amsterdam, NH, NL
Tim Schenk Work
Chief Business Officer @ (August 2023 - Present)
General Manager Finland @ (January 2020 - August 2023)
Commercial Director Nordics @ (July 2016 - January 2020)
Head of Oncology Germany @ (November 2014 - June 2016)
General Manager @ (November 2013 - October 2014)
Global Business Lead Marketed Products @ (November 2011 - November 2013)
VP Global Business Lead Travel Vaccines @ (January 2009 - November 2011)
Director Business Development @ (March 2006 - December 2008)
Sr Management Consultant @ (December 2004 - February 2006)
R and D Project Manager @ Kiadis Pharma (January 1997 - October 2004)
PhD Studies and R and D Project Manager @ Screentec (February 1997 - September 2001)
PhD student @ Leiden Amsterdam Center for Drug Research (January 1997 - January 2001)
Tim Schenk Education
Rotterdam School of Management, Erasmus University
MBA
2007-2008
Leiden University
PhD (Analytical Chemistry)
1997-2001
Leiden University
Masters (BioPharmaceutical Sciences)
1992-1996
Tim Schenk Skills
Technology Transfer
Biotechnology
Lifesciences
GMP
R&D
Pharmaceutical Industry
Immunology
Regulatory Affairs
Clinical Trials
Life Sciences
Molecular Biology
Vaccines
Biopharmaceuticals
Drug Discovery
Chromatography
Management
Sop
Clinical Development
Cell
Biochemistry
Regulatory Submissions
Drug Development
Infectious Diseases
Commercialization
Protein Chemistry
Tim Schenk Summary
Tim Schenk, based in Amsterdam, NH, NL, is currently a Chief Business Officer at Citryll. Tim Schenk brings experience from previous roles at The Janssen Pharmaceutical Companies of Johnson & Johnson and Crucell Switzerland AG. Tim Schenk holds a 2007 - 2008 MBA @ Rotterdam School of Management, Erasmus University. With a robust skill set that includes Technology Transfer, Biotechnology, Lifesciences, GMP, R&D and more. Tim Schenk has 1 emails on RocketReach.
Looking for a different Tim Schenk?
Find contact details for 700 million professionals.